Coffee-based approach yields promising results in ovarian cancer trial
University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...
PharmExec7h
Winrevair Found to Significantly Reduce the Risk of Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension
Results from the Phase III ZENITH trial show that Winrevair lowered the risk of all-cause death, lung transplantation, and ...
NSW Government16h
Next phase of $830 million Liverpool Hospital redevelopment under way
Demolition works as part of preparations for the second phase of the Liverpool Health and Academic Precinct (LHAP) redevelopment of Liverpool Hospital will begin this month.
T-Cell Acute Lymphoblastic Leukemia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...
Advanced Cervical Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...
NIH is the largest funder of cancer research. Here's how Trump administration cuts could impact patients.
The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.
The Manila Times20h
I-Mab Reports Full Year 2024 Financial Results and Provides Business Update
I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in the U.S.
NETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION
CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...
Rolling Out22h
Sleep phases that could protect your brain from Alzheimer’s
Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...
Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data
Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.